PE4S217 - Personalised Weight Management (2): Medical Treatments and Emerging Therapies 01 Sep 2021 - 31 Aug 2027 | Version 1
Associated Module Information
| Module Code: | PE4S217 | ||
|---|---|---|---|
| Module Title: | Personalised Weight Management (2): Medical Treatments and Emerging Therapies | ||
| Faculty: | Faculty of Life Sciences and Education | ||
| Faculty Group: | Allied Health and Chiropractic | ||
| Faculty Sub Group: | Clinical Services | ||
| Module Leader: | Karl New | ||
| Module Team: | |||
| First Intended Intake: | SEP 2021 | Final Year of Intake: | |
| Date Closed: | |||
| Credit Value: | 20 | Credit Level: | 7 |
| Language: | English | ||
| Percentage of Module Taught in Welsh: | 0 | ||
| Equivalent Module: | |||
| HECOS codes: | 100260 - healthcare science | ||
| HECOS Code Weighting: | 100 | ||
Document Version Information
| Version | 1 |
|---|---|
| Valid From | 01 Sep 2021 |
| Valid To | 31 Aug 2027 |
Module Aims
To enhance the knowledge and clinical skills required to effectively evaluate and treat obesity with emphasis on personalised care, pharmacotherapy and new and emerging therapies.
Content Summary
• Analysis of specific guidelines for obesity pharmacotherapy.
• The role and clinical applicability of medical therapies in weight management.
• The pharmacological effects, mechanism of action, efficacy and adverse events associated with licensed medical therapies used in weight management and evaluation of the evidence.
• Unlicensed therapies used in weight management, their pharmacological properties, evidence regarding their use, controversies and legalities of use, and the associated adverse effects.
• Previously licensed/used medical therapies, their pharmacology and reasons for withdrawal with an emphasis upon pharmacovigilance and post marketing surveillance.
• The role of emerging therapies in weight management with emphasis upon the physiological basis for potential therapies.
Learning and Teaching Methods
| Activity Type | Hours |
|---|---|
| Independent Study | 100 |
| Directed Study | 100 |
| Total Hours Selected | 200 |
Learning Outcomes
| # | Learning Outcome |
|---|---|
| LO1 | Demonstrate a critical understanding of medical therapies used in the clinical treatment of obesity and application of this understanding to the personalised care of the person living with obesity |
| LO2 | Demonstrate a critical understanding of past, current, new and emerging therapies for weight management and the role of pharmacovigilance in evaluating their adverse effects. |
Module Requisites
N/A
Assessment Criteria
| Assessment Category | Assessment Type | Description | Duration | Word Count | Weight (%) | Best of? | Pass Mark |
|---|---|---|---|---|---|---|---|
| Synchronous Online Assessment | Time-constrained assessment (Online) 1 | End of Module examination related to personalised weight management using medical treatments and emerging therapies | 60 | N/A | 30 | No | 40 |
| Asynchronous Assessment | Self Reflective Assessment 1 | Reflective Journal | 0 | 600 | 10 | No | 40 |
| Asynchronous Assessment | Project 1 | Completion of a group task related to personalised weight management using medical treatments and emerging therapies | 0 | N/A | 20 | No | 40 |
| Asynchronous Assessment | Case study 1 | Case based scenarios and discussion forum related to personalised weight management using medical treatments and emerging therapies | 0 | N/A | 40 | No | 40 |
Assessment Matrix
| Assessment Type | Learning Outcomes | ||
|---|---|---|---|
| LO1 | LO2 | ||
| Time-constrained assessment (Online) 1 | ✔ | ✔ | |
| Self Reflective Assessment 1 | ✔ | ✔ | |
| Project 1 | ✔ | ✔ | |
| Case study 1 | ✔ | ✔ | |